Ameriprise Financial Inc Ascendis Pharma A/S Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Ameriprise Financial Inc holds 669,717 shares of ASND stock, worth $93 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

669,717

Previous 660,662 1.37%

Holding current value

$93 Million

Previous $90.1 Million 11.0%

% of portfolio

0.03%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$113.0 - $153.43 $1.02 Million - $1.39 Million	9,055 Added 1.37%	669,717 $100 Million
Q2 2024 Aug 14, 2024	BUY	$121.07 - $153.67 $73.3 Million - $93 Million	605,496 Added 1097.59%	660,662 $90.1 Million
Q1 2024 May 15, 2024	SELL	$123.45 - $159.4 $881,926 - $1.14 Million	-7,144 Reduced 11.47%	55,166 $8.34 Million
Q4 2023 Feb 14, 2024	BUY	$86.1 - $127.36 $149,297 - $220,842	1,734 Added 2.86%	62,310 $7.85 Million
Q3 2023 Nov 14, 2023	SELL	$86.5 - $103.97 $695,719 - $836,230	-8,043 Reduced 11.72%	60,576 $5.67 Million
Q2 2023 Aug 14, 2023	BUY	$69.96 - $97.84 $1.02 Million - $1.43 Million	14,586 Added 26.99%	68,619 $6.12 Million
Q1 2023 May 15, 2023	SELL	$104.9 - $126.78 $10,804 - $13,058	-103 Reduced 0.19%	54,033 $5.79 Million
Q4 2022 Feb 14, 2023	SELL	$99.42 - $131.97 $32,908 - $43,682	-331 Reduced 0.61%	54,136 $6.61 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $361,497 - $474,209	4,302 Added 8.58%	54,467 $5.63 Million
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $128,363 - $193,350	-1,644 Reduced 3.17%	50,165 $4.66 Million
Q1 2022 May 16, 2022	BUY	$102.18 - $135.75 $330,245 - $438,744	3,232 Added 6.65%	51,809 $6.08 Million
Q4 2021 Feb 14, 2022	SELL	$127.1 - $169.66 $331,731 - $442,812	-2,610 Reduced 5.1%	48,577 $6.54 Million
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $151,428 - $237,780	-1,344 Reduced 2.56%	51,187 $8.16 Million
Q2 2021 Aug 16, 2021	BUY	$121.62 - $145.29 $546,560 - $652,933	4,494 Added 9.36%	52,531 $6.91 Million
Q1 2021 May 17, 2021	SELL	$124.92 - $173.33 $2.76 Million - $3.83 Million	-22,119 Reduced 31.53%	48,037 $6.19 Million
Q4 2020 Feb 12, 2021	SELL	$151.2 - $182.76 $404,308 - $488,700	-2,674 Reduced 3.67%	70,156 $11.7 Million
Q3 2020 Nov 16, 2020	SELL	$134.29 - $154.32 $125,292 - $143,980	-933 Reduced 1.26%	72,830 $11.2 Million
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $6,763 - $9,516	61 Added 0.08%	73,763 $10.9 Million
Q1 2020 May 15, 2020	SELL	$97.01 - $145.11 $2.4 Million - $3.59 Million	-24,731 Reduced 25.12%	73,702 $8.3 Million
Q4 2019 Feb 14, 2020	BUY	$91.45 - $139.12 $21,948 - $33,388	240 Added 0.24%	98,433 $13.7 Million
Q3 2019 Nov 14, 2019	SELL	$95.8 - $118.9 $750,880 - $931,938	-7,838 Reduced 7.39%	98,193 $9.46 Million
Q2 2019 Aug 14, 2019	BUY	$107.11 - $132.09 $4.55 Million - $5.61 Million	42,448 Added 66.76%	106,031 $12.2 Million
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $3.95 Million - $8.27 Million	63,583 New	63,583 $7.48 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.75B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Ascendis Pharma A/S Transaction History